help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coste, S. C.
Right arrow Articles by Stenzel-Poore, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coste, S. C.
Right arrow Articles by Stenzel-Poore, M. P.
Endocrinology Vol. 142, No. 8 3537-3545
Copyright © 2001 by The Endocrine Society

ARTICLES

IL-1{alpha} and TNF{alpha} Down-Regulate CRH Receptor-2 mRNA Expression in the Mouse Heart

Sarah C. Coste1, Kurt A. Heldwein1, Susan L. Stevens, Eric Tobar-Dupres and Mary P. Stenzel-Poore

Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, Oregon 97201

Address all correspondence and requests for reprints to: Mary P. Stenzel-Poore, Ph.D., Department of Molecular Microbiology and Immunology, L220, Oregon Health Sciences University, 3181 Southwest Sam Jackson Park Road, Portland, Oregon 97201. E-mail: poorem{at}ohsu.edu

Two receptors (CRH receptor type 1 and CRH receptor type 2) have been identified for the stress-induced neuropeptide, CRH and related peptides, urocortin, and urocortin II. We previously found marked down-regulation of cardiac CRH receptor type 2 expression following administration of bacterial endotoxin, lipopolysaccharide, a model of systemic immune activation, and inflammation. We postulated that inflammatory cytokines may regulate CRH receptor type 2. We show that systemic IL-1{alpha} administration significantly down-regulates CRH receptor type 2 mRNA in mouse heart. In addition, TNF{alpha} treatment also reduces CRH receptor type 2 mRNA expression, although the effect was not as marked as with IL-1{alpha}. However, CRH receptor type 2 mRNA expression is not altered in adult mouse ventricular cardiomyocytes stimulated in vitro with TNF{alpha} or IL-1{alpha}. Thus, cytokine regulation may be indirect. Exogenous administration of corticosterone in vivo or acute restraint stress also reduces cardiac CRH receptor type 2 mRNA expression, but like cytokines, in vitro corticosterone treatment does not modulate expression in cardiomyocytes. Interestingly, treatment with urocortin significantly decreases CRH receptor type 2 mRNA in cultured cardiomyocytes. We speculate that in vivo, inflammatory mediators such as lipopolysaccharide and/or cytokines may increase urocortin, which in turn down-regulates CRH receptor type 2 expression in the heart. Because CRH and urocortin increase cardiac contractility and coronary blood flow, impaired CRH receptor type 2 function during systemic inflammation may ultimately diminish the adaptive cardiac response to adverse conditions.




This article has been cited by other articles:


Home page
 FASEB J.Home page
Y. Sztainberg, Y. Kuperman, O. Issler, S. Gil, J. Vaughan, J. Rivier, W. Vale, and A. Chen
A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease
FASEB J, July 1, 2009; 23(7): 2186 - 2196.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
K. Ikeda, K. Tojo, Y. Inada, Y. Takada, M. Sakamoto, M. Lam, W. C Claycomb, and N. Tajima
Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes
J. Mol. Endocrinol., June 1, 2009; 42(6): 479 - 489.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M. Huang, D. Kempuraj, N. Papadopoulou, T. Kourelis, J. Donelan, A. Manola, and T. C Theoharides
Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-{kappa}B activation
J. Mol. Endocrinol., May 1, 2009; 42(5): 397 - 405.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff
Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.
Physiol Rev, October 1, 2006; 86(4): 1309 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
N. G Papadopoulou, L. Oleson, D. Kempuraj, J. Donelan, C. L Cetrulo, and T. C Theoharides
Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells
J. Mol. Endocrinol., December 1, 2005; 35(3): R1 - R8.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Chen, M. Perrin, B. Brar, C. Li, P. Jamieson, M. DiGruccio, K. Lewis, and W. Vale
Mouse Corticotropin-Releasing Factor Receptor Type 2{alpha} Gene: Isolation, Distribution, Pharmacological Characterization and Regulation by Stress and Glucocorticoids
Mol. Endocrinol., February 1, 2005; 19(2): 441 - 458.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Kageyama, C. Li, and W. W. Vale
Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids
Endocrinology, April 1, 2003; 144(4): 1524 - 1532.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society